Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) agreed to acquire Zhengzhou Qianxitang Medicine Co.,ltd. from Zhengzhou Pharmaceutical Co Ltd on January 6, 2016. The consideration comprises of CNY 180 million of internal funds and other money. Yunnan Hongxiang Yixintang Pharmaceutical Co.'s President's Office held its 2016 1st meeting and approved the transaction. This transaction does not require the approval from the directorate.

Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) completed the acquisition of Zhengzhou Qianxitang Medicine Co.,ltd. from Zhengzhou Pharmaceutical Co Ltd on February 2, 2016.